MedTrace Logo

Amlodipine Plus/Minus Atorvastatin for Protection of Arteries

NCT01922687 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2013-08-14

No results posted yet for this study

Summary

The primary objective of this study is to test the hypothesis that amlodipine plus atorvastatin given in a single tablet (Caduet), compared with amlodipine alone (Norvasc), has a stronger effect in protection of arterial structure and function.

Conditions

  • Arterial and Arteriolar Disorders

Interventions

DRUG

amlodipine plus atorvastatin (Caduet)

DRUG

amlodipine (Norvasc)

Sponsors & Collaborators

  • Shanghai Institute of Hypertension

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2014-03-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01922687 on ClinicalTrials.gov